PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.010
-0.080 (-7.34%)
At close: Apr 1, 2025, 4:00 PM
1.025
+0.015 (1.46%)
After-hours: Apr 1, 2025, 7:57 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-58.71-68.96-73.32-57.85-34.44
Upgrade
Depreciation & Amortization
1.141.260.320.310.32
Upgrade
Loss (Gain) From Sale of Assets
0.06----
Upgrade
Loss (Gain) From Sale of Investments
-5.37-5.39-0.630.550.15
Upgrade
Stock-Based Compensation
8.8712.3810.25.341.93
Upgrade
Other Operating Activities
4.31-0.370.240.960.14
Upgrade
Change in Accounts Payable
3.340.24-0.390.19-1.23
Upgrade
Change in Other Net Operating Assets
-4.935.19-0.183.930.39
Upgrade
Operating Cash Flow
-51.28-55.66-63.76-46.57-32.74
Upgrade
Capital Expenditures
-0.66-0.96-7.98-1.35-0.15
Upgrade
Sale of Property, Plant & Equipment
0.25----
Upgrade
Investment in Securities
53.76-49.586.62-142.2428.06
Upgrade
Investing Cash Flow
53.35-50.55-1.37-143.5827.91
Upgrade
Issuance of Common Stock
0.3135.580.962.02243.54
Upgrade
Other Financing Activities
-----20.57
Upgrade
Financing Cash Flow
0.3135.580.962.02292.97
Upgrade
Foreign Exchange Rate Adjustments
-0.040.03---
Upgrade
Net Cash Flow
2.35-70.59-64.17-188.13288.14
Upgrade
Free Cash Flow
-51.94-56.62-71.74-47.92-32.89
Upgrade
Free Cash Flow Per Share
-1.01-1.18-1.57-1.06-2.29
Upgrade
Cash Income Tax Paid
---0.020.01
Upgrade
Levered Free Cash Flow
-44.68-32.94-48.97-27.51-20.58
Upgrade
Unlevered Free Cash Flow
-44.68-32.94-48.97-27.51-20.58
Upgrade
Change in Net Working Capital
1.01-4.473.34-4.620.85
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q